Autres langues Vista Pharmaceuticals Limited

Actions

VISTAPH6

INE427C01021

Produits pharmaceutiques

Temps Différé Bombay S.E. 09:46:04 15/09/2026			Varia. 5j.	Varia. 1 janv.
5,900 ^INR	+2,61%		+1,72%	-27,52%

14/08	Vista Pharmaceuticals Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
13/02	Vista Pharmaceuticals Limited publie ses résultats financiers pour le troisième trimestre et les neuf premiers mois clos le 31 décembre 2025	CI

Autres langues

14/08	Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
13/02	Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
03/02	Vista Pharmaceuticals enters joint venture with Pleiades Therapeutics
13/08/25	Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
16/07/25	Vista Pharmaceuticals Limited announced that it has received INR 30.749994 million in funding
30/05/25	Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
19/02/25	Vista Pharmaceuticals Limited announced that it expects to receive INR 146.614482 million in funding
12/02/25	Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
13/11/24	Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
13/08/24	Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
28/05/24	Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
10/02/24	Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
08/01/24	Vista Pharmaceuticals Limited announced that it expects to receive INR 0.533334 million in funding
10/11/23	Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
12/08/23	Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
16/06/23	Vista Pharmaceuticals Limited Announces the Resignation of Mr. Nishant Talreja from the Post of Company Secretary, Compliance Officer and Key Managerial Personnel
30/05/23	Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
10/04/23	Vista Pharmaceuticals Limited Announces Change in Corporate Office Address
13/02/23	Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
14/12/22	Vista Pharmaceuticals Limited announced that it has received INR 61.895 million in funding
15/11/22	Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
20/10/22	Vista Pharmaceuticals Appoints Chairman
14/10/22	Vista Pharmaceuticals Limited Announces Executive Changes
08/09/22	Vista Pharmaceuticals Limited Approves Resignation of Narendra Gilaka as Independent Director of the Company
03/09/22	Vista Pharmaceuticals Limited announced that it expects to receive INR 66.895 million in funding